Atrility Medical, which was launched by a pediatric heart surgeon who noticed recurring issues in some operations, won with its plan for bringing AtriAmp to market.

The device eases efficient monitoring and treatment of atrial arrhythmia, which is a rhythm disruption difficult to pick up with current equipment. Undetected, the condition can cause complications, extra costs and even death.

Dr. Nick Von Bergen presented for the company, which includes a larger team of scientists and managers. AtriAmp has been cleared for use by the FDA. Like 11 other “Diligent Dozen” finalists, Von Bergen presented Wednesday to judges and others during a prelude to the Wisconsin Entrepreneurs’ Conference.

See a recent article on the company: